skip to Main Content
Cannabis Vape Companies Saw Bootlegs Coming — So Why Didn’t Regulators?

Despite the efforts of cannabis companies to keep up with counterfeit carts, people are still getting sick

If imitation is the highest form of flattery, you’d think Kingpen, a popular California-based cannabis brand, would be positively tickled by the fact that they make one of the most widely counterfeited vape cartridges on the market. But with a mysterious lung disease putting both manufacturers and consumers on high alert, Kingpen’s parent company Loudpack is especially worried. “I think it’s very scary what’s happening right now,” says Danny Corral, Loudpack’s vice president of sales. There’s a lot of bootleg product that’s going out there and flooding the market and getting people sick. I think that the perception of the product is getting tainted in that way.”

For two months, there’s been a flood of stories about the mysterious illness apparently connected to vaping that’s sent hundreds to the hospital and is linked with several deaths. As speculation about what might be causing the illness spreads, the Center for Disease Control is warning against vaporizer usage, and both federal and state-level bans on flavored vape pods are going into effect, ostensibly to keep kids away from potentially dangerous cartridges. With over 1,000 cases and at least 19 deaths potentially caused by vaping, people are asking questions about how the problem started, why it grew so out of control, and what can be done to prevent any more harm. But for cannabis companies who have been operating legally for years, there’s another burning question: How did regulators not see this coming? [Read More @ Rolling Stone]

 

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

Kentucky’s Medical Cannabis Program Undergoes Dramatic Transformation: Navigating HB 829 and the Emergency Licensing Regulations

By Hannah King and Arin Aragona Plans for Kentucky’s medical cannabis program took a significant turn last week with the passage of House Bill 829 and the implementation of emergency…

Cannabis in Court: When Federal Courts Will Hear Commercial Disputes Related to the Cannabis Business

By Steven Ascher and Anna M.Windemuth The unique status of the cannabis business —  legal in a majority of states, but still illegal under federal law — creates a thorny…

Patchwork Regulation of CBD Products Continues Despite Rise in Demand

By Courtney A. Hunter and Jessalyn H. Zeigler Demand for cannabidiol (CBD) products continues to climb, and the market has risen to the occasion. There is now a robust array…

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

More Categories

Back To Top
×Close search
Search